Ausgabe 3/2017
Inhalt (24 Artikel)
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
B. Cabarrou, L. Mourey, F. Dalenc, L. Balardy, D. Kanoun, H. Roché, J. M. Boher, M. E. Rougé-Bugat, Thomas Filleron
Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer
Kathryn J. Ruddy, Holly K. Van Houten, Lindsey R. Sangaralingham, Rachel A. Freedman, Carrie A. Thompson, Shahrukh K. Hashmi, Ahmedin Jemal, Tufia C. Haddad, Sarah Mougalian, Jeph Herrin, Cary Gross, Nilay Shah
Critical appraisal of health-state utility values used in breast cancer-related cost–utility analyses
Virginie Nerich, Sopany Saing, Eva-Maria Gamper, Bernhard Holzner, Xavier Pivot, Rosalie Viney, Georg Kemmler
Risk of death from cardiovascular disease following breast cancer: a systematic review
S. A. M. Gernaat, P. J. Ho, N. Rijnberg, M. J. Emaus, L. M. Baak, M. Hartman, D. E. Grobbee, H. M. Verkooijen
Benefit of adding digital breast tomosynthesis to digital mammography for breast cancer screening focused on cancer characteristics: a meta-analysis
Seong Jong Yun, Chang-Woo Ryu, Sun Jung Rhee, Jung Kyu Ryu, Ji Young Oh
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)
Diep Ho, Jessica Huang, Judith-Anne W. Chapman, Kim Leitzel, Suhail M. Ali, Lois Shepherd, Wendy R. Parulekar, Catherine E. Ellis, Rocco J. Crescnzo, Liting Zhu, Shakeel Virk, Dora Nomikos, Samuel Aparicio, Karen A. Gelmon, Walter P. Carney, Allan Lipton
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
Gail D. Lewis Phillips, Merry C. Nishimura, Jennifer Arca Lacap, Samir Kharbanda, Elaine Mai, Janet Tien, Kimberly Malesky, Simon P. Williams, Jan Marik, Heidi S. Phillips
Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer
Seth K. Rummel, Leann Lovejoy, Craig D. Shriver, Rachel E. Ellsworth
Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer
Madhura G. Kelkar, Bhushan Thakur, Abhishek Derle, Sushmita Chatterjee, Pritha Ray, Abhijit De
A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy
Ji-Yeon Kim, Oh Nam Ok, Jeong-ju Seo, Soo-Hyeon Lee, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
Kara N. Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, Andrea B. Troxel, Candace Clark, Michael Feldman, Christopher Colameco, Bijal Kakrecha, Melissa Langer, David Lieberman, Jennifer J. D. Morrissette, Matt R. Paul, Tien-chi Pan, Stephanie Yee, Natalie Shih, Erica Carpenter, Lewis A. Chodosh, Angela DeMichele
Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
Kara N. Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, Andrea B. Troxel, Candace Clark, Michael Feldman, Christopher Colameco, Bijal Kakrecha, Melissa Langer, David Lieberman, Jennifer J. D. Morrissette, Matt R. Paul, Tien-chi Pan, Stephanie Yee, Natalie Shih, Erica Carpenter, Lewis A. Chodosh, Angela DeMichele
Radiation and depression associated with complications of tissue expander reconstruction
Paul J. Chuba, William A. Stefani, Carrie Dul, Susan Szpunar, Jeffrey Falk, Rachael Wagner, Elango Edhayan, Anna Rabbani, Cynthia H. Browne, Amr Aref
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
Denise A. Yardley, Edward R. Arrowsmith, Brooke R. Daniel, Janice Eakle, Adam Brufsky, David R. Drosick, Fred Kudrik, Linda D. Bosserman, Mark R. Keaton, Sharon A. Goble, Jeffrey A. Bubis, Victor M. Priego, Kelly Pendergrass, Yvonne Manalo, Martin Bury, Donald S. Gravenor, Gladys I. Rodriguez, Roger C. Inhorn, Robyn R. Young, William N. Harwin, Caryn Silver, John D. Hainsworth, Howard A. Burris III
Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography
Elizabeth A. Rafferty, Stephen L. Rose, Dave P. Miller, Melissa A. Durand, Emily F. Conant, Debra S. Copit, Sarah M. Friedewald, Donna M. Plecha, Ingrid L. Ott, Mary K. Hayes, Kara L. Carlson, Thomas M. Cink, Lora D. Barke, Linda N. Greer, Loren T. Niklason
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
Cecilia Ahlin, Claudia Lundgren, Elin Embretsén-Varro, Karin Jirström, Carl Blomqvist, M. -L. Fjällskog
Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™
Cecilia Dahlbäck, Jenny Heiman Ullmark, Martin Rehn, Anita Ringberg, Jonas Manjer
Elevated T cell activation score is associated with improved survival of breast cancer
Lingeng Lu, Yalai Bai, Zuoheng Wang
Childhood and teenage physical activity and breast cancer risk
Nicole M. Niehoff, Alexandra J. White, Dale P. Sandler
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction
Molly Scannell Bryan, Maria Argos, Irene L. Andrulis, John L. Hopper, Jenny Chang-Claude, Kathleen Malone, Esther M. John, Marilie D. Gammon, Mary Daly, Mary Beth Terry, Saundra S. Buys, Dezheng Huo, Olofunmilayo Olopade, Jeanine M. Genkinger, Farzana Jasmine, Muhammad G. Kibriya, Lin Chen, Habibul Ahsan
Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results
Anand Narayan, Alexander Fischer, Zihe Zhang, Ryan Woods, Elizabeth Morris, Susan Harvey
Women with breast cancer report substantially more disease- and treatment-related side or late effects than registered by clinical oncologists: a cross-sectional study of a standard follow-up program in an oncological department
Mai-Britt Bjørklund Ellegaard, Cai Grau, Robert Zachariae, Anders Bonde Jensen
Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients
Andy Göbel, Jan D. Kuhlmann, Theresa Link, Pauline Wimberger, Andrew J. Browne, Martina Rauner, Lorenz C. Hofbauer, Tilman D. Rachner
Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
Jessica A. Cintolo-Gonzalez, Danielle Braun, Amanda L. Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K. Plichta, Molly Griffin, Kevin S. Hughes